Dr. Mark Charlie Valente is a Plano, Texas based male orthopedic surgeon who is specialized in Orthopaedic Surgery of the Spine. Active license number of Dr. Mark Charlie Valente is N7365 for Orthopaedic Surgery of the Spine in Texas.
Dr. Mark Charlie Valente deals with the evaluation and nonoperative and operative treatment of the full spectrum of primary spinal disorders including trauma, degenerative, deformity, tumor, and reconstructive.
Complete Profile:
Dr. Mark Charlie Valente speciality, credentials, practice address, contact phone number and fax are as below.
Patients can directly walk in or can call on the below given phone number for appointment.
Specialization:
Orthopedic - Orthopaedic Surgery of the Spine
Credentials:
D.O.
Gender:
Male
Practice Address:
6200 Preston Rd Ste 300, Plano, Texas, 75024-2619
Phone:
972-707-0005
Fax:
888-992-6199
Professional Identification Codes:
NPI number stands for National Provider Identifier which is a unique 10-digit identification number issued to health care providers in the United States by the Centers for Medicare and Medicaid Services (CMS).
NPI details are as mentioned below.
NPI Number:
1194930453
NPI Enumeration Date:
11 May, 2007
NPI Last Update On:
27 May, 2021
Medical Licenses:
Doctors can have one or more medical licenses for different specialities in the same state or different states. Related medical licenses for Dr. Mark Charlie Valente are as mentioned below.
License Number
Specialization
State
Status
N7365
Orthopaedic Surgery of the Spine
Texas
Primary
Business Mailing Address:
Business mailing address can be used for mailing purpose only, for visiting purpose patients need to refer above mentioned address.
Address:
6200 Preston Rd Ste 300, Plano, Texas
Zip:
75024-2619
Phone Number:
972-707-0005
Fax Number:
888-992-6199
Patients can reach Dr. Mark Charlie Valente at 6200 Preston Rd Ste 300, Plano, Texas or can call to book an appointment on 972-707-0005. Data of this site is collected from Medicare & Medicaid Services (CMS) and NPPES. Last updated on 11 March, 2024.